The Bayer DCA 2000 + is a fully automated chemical analyzers. It
is often the most workable choice to acquire results for hemoglobin A1c and
microalbumin/creatinine tests in minutes. The manufacturer of this point-of-care
diabetes management platform is Bayer Diagnostics (a division of Siemens).
This analyzer is useful to make immediate diabetes management adjustments,
and thus protect the patients from the risks of retinopathy, neuropathy, and
nephropathy. With this device, you can calculate low concentrations of albumin,
creatinine and albumin/creatinine ratio in urine.
Bayer DCA 2000 +, better known for its accuracy and easy procedures, can
produce the quantitative HbA1c value in 6 minutes. The features specific to DCA
2000 + are self-contained reagent cartridges (that means no reagent
preparation, mixing, or handling), no costly, time-consuming calibration, sample
collection capillary holder, screen displays (which provides full testing
information, instructions, and calibration status), and adjust blood glucose control
outstanding accuracy and precision, monoclonal antibody method is
utilized. It has the ability to store 16 test results in memory for
convenient retrieval of data.
HbA1c and A:C Ratio
testing results in just six and seven minutes, respectively.
comfort by requiring a smaller whole blood sample (1 uL) for HbA1c.
patient trend graph.
Online GFR calculator
provides a tool for kidney disease staging.
Improved clinical confidence:
- Proven to provide accurate and precise lab-quality results.
- Barcode patient data entry to reduce transcription errors.
- Onboard printed results; eliminates transcription errors and saves
- Automatically uploads results to a LIS/HIS.
- Largest memory stores up to 4000 records; easily downloaded and
transferred to a PC.
- Add sample to test cartridge, load, and walk away.
- No sample or reagent preparation.
- Color touch screen display; easier menu navigation, data entry and
- Minimal maintenance required with automatic reminders.
reagent cartridges — no reagent preparation, mixing or handling
Sample collection capillary holder
is an integral part of unique reagent cartridge
No costly, time-consuming
calibration — factory-calibrated instrument eliminates all wet
Screen displays all
instructions, calibration status and testing information and results
Up to 16 results stored in
memory for convenient recordkeeping
Laboratory-accurate results just minutes after
Review during patient visit,
adjust blood glucose control regimen as appropriate
Conforms with current
guidelines for effective management
HbA1c results…in minutes
Guide and reinforce your
patients to maintain target blood glucose levels
Quantitative HbA1c value in 6
minutes from capillary blood Low cost per test
Monoclonal antibody method
provides outstanding accuracy and precision
Correlation study shows 99%
agreement with the HPLC method
Coefficients of variation
<5% show excellent precision
Microalbumin/Creatinine ratio…in minutes
In IDDM (insulin-dependent
diabetes mellitus) patients, intensive insulin treatment:
Delays the onset and
slows the progression of microvascular complications
financial savings when part of long-term monitoring and control
One reagent cartridge
provides results for both microalbumin and creatinine as well as an
automatic calculation of the albumin-to-creatinine ratio
Quantitative results and
calculated ratio displayed within 7 minutes using random urine sample.
Intensive management improves glycemic control
Maintaining average blood
glucose levels (120 mg/dL; 6.7 mmol/L; HbA1c 6%) lowers risk of
Three- to four-times-daily
blood glucose monitoring is recommended.
Establish and follow a
coherent approach of combined nutritional counseling, self-management
training and possible hospitalization for therapy initiation.
Reduce the risk. Monitor HbA1c levels
HbA1c results monitor glucose
control over the preceding 90 to 120 days.
Complete normalization of
glycemia levels may prevent complications.
Quarterly HbA1c determination
recommended for all insulin-treated patients.
Recommendation also includes
test for microalbuminuria and others, as indicated
Detect early stages of diabetic nephropathy. Protect
your patient from complications
Intensive diabetes management
delays the onset of microalbuminuria -an early indicator of renal disease.
ratio from a random urine sample is as valid an indicator of
microalbuminuria as a timed 24-hour sampling.
(30 to 300 mg/day) indicates the earliest stage of diabetic nephropathy.
May also signal presence of
hypertension and the need to begin antihypertensive therapy.
Test for microalbuminuria
should be performed yearly on postpubertal patients who have had diabetes
for at least 5 years.
Please note that this sale does not include accessories or the disposables.
100% Secure Ordering
Verisign Secure Server
We Value Your Privacy
No Hassle Return Policy
Great Customer Service
Honesty, integrity, persistent with service...wholehearted recommendation petehillnp– Los Angeles, CA
Excellent product & service. Will definitely do business with Absolute Medical again, countmonk– Chicago, IL
Honesty, integrity, persistent with service...wholehearted recommendation petehillnp– Miami, FL
Excellent product & service. Will definitely do business with Absolute Medical again, countmonk– Houston, TX